Traci M. Blonquist

Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial

Andrew E. Place, Kristen E. Stevenson, Lynda M. Vrooman et al. · The Lancet Oncology · 2015 · 240 citations

Medicine, Oncology, Pediatrics +8

Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001

Lynda M. Vrooman, Traci M. Blonquist, Marian H. Harris et al. · Blood Advances · 2018 · 115 citations · Full text

Medicine, Hematology, Oncology +12

Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent

Michael Xiang, Haesook Kim, Vincent T. Ho et al. · Blood · 2016 · 113 citations · Full text

Medicine, Oncology, Pharmacology +9

Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana‐Farber Cancer Institute ALL Consortium Protocols (2000–2010)

Kira Bona, Traci M. Blonquist, Donna Neuberg et al. · Pediatric Blood & Cancer · 2016 · 109 citations

Medicine, Child Health, Oncology +17

Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis

Maryam Movassaghian, Andrew M. Brunner, Traci M. Blonquist et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 94 citations

Medicine, Oncology, Hematologic Oncology +12